Donation after circulatory death with thoracoabdominal normothermic regional perfusion recovery has similar outcomes with donation after brain death for lung transplantation
Sarah Y. Park MD , Emily Hay-Arthur BA , Elizabeth J. Bashian MD , Han Le MS , Michal Schäfer MD, PhD , David N. Campbell MD , Nicholas R. Teman MD , Alice L. Gray MD , Jordan R.H. Hoffman MD, MPH , Michael T. Cain MD
{"title":"Donation after circulatory death with thoracoabdominal normothermic regional perfusion recovery has similar outcomes with donation after brain death for lung transplantation","authors":"Sarah Y. Park MD , Emily Hay-Arthur BA , Elizabeth J. Bashian MD , Han Le MS , Michal Schäfer MD, PhD , David N. Campbell MD , Nicholas R. Teman MD , Alice L. Gray MD , Jordan R.H. Hoffman MD, MPH , Michael T. Cain MD","doi":"10.1016/j.jhlto.2025.100289","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Donation after circulatory death (DCD) with thoracoabdominal normothermic regional perfusion (TA-NRP) has been increasingly used to procure cardiac allografts; however, concerns persist regarding its impact on lung allografts. We present our institution’s experience with DCD TA-NRP and donation after brain death (DBD) lung transplants, comparing outcomes between the two techniques.</div></div><div><h3>Methods</h3><div>All lung transplants recovered with DBD or DCD TA-NRP performed between October 2022 and December 2024 were included. DCD TA-NRP procured lungs were retrieved using a lung protective strategy including early reintubation and pulmonary venting as previously described. The primary outcome was survival, with secondary outcomes of primary graft dysfunction (PGD) and pulmonary-related mortality.</div></div><div><h3>Results</h3><div>There were 85 DBD and 23 DCD TA-NRP lung transplants performed in the study period. Overall survival was not significantly different by Kaplan-Meier curve (<em>p</em> = 0.49), with 1-year absolute survival of 81.6% for DCD TA-NRP, with only one pulmonary-related mortality, and 89.4% for DBD, with six pulmonary-related mortalities. PGD grade 3 rates were not statistically different at postoperative day (POD) 0 (47.8% DCD TA-NRP vs 35.2% DBD, <em>p</em> = 0.27), POD 1 (21.7% vs 10.6%, <em>p</em> = 0.16), POD2 (8.7% vs 11.7%, <em>p</em> = 0.68), and POD3 (13.0% vs 11.8%, <em>p</em> = 0.87). Other intraoperative and postoperative outcomes were not significantly different.</div></div><div><h3>Conclusion</h3><div>Lung transplantation outcomes were not significantly different between lung grafts recovered by DCD TA-NRP and DBD. This early data suggests TA-NRP may not adversely impact DCD lung allografts during procurement.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"9 ","pages":"Article 100289"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JHLT Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950133425000849","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Donation after circulatory death (DCD) with thoracoabdominal normothermic regional perfusion (TA-NRP) has been increasingly used to procure cardiac allografts; however, concerns persist regarding its impact on lung allografts. We present our institution’s experience with DCD TA-NRP and donation after brain death (DBD) lung transplants, comparing outcomes between the two techniques.
Methods
All lung transplants recovered with DBD or DCD TA-NRP performed between October 2022 and December 2024 were included. DCD TA-NRP procured lungs were retrieved using a lung protective strategy including early reintubation and pulmonary venting as previously described. The primary outcome was survival, with secondary outcomes of primary graft dysfunction (PGD) and pulmonary-related mortality.
Results
There were 85 DBD and 23 DCD TA-NRP lung transplants performed in the study period. Overall survival was not significantly different by Kaplan-Meier curve (p = 0.49), with 1-year absolute survival of 81.6% for DCD TA-NRP, with only one pulmonary-related mortality, and 89.4% for DBD, with six pulmonary-related mortalities. PGD grade 3 rates were not statistically different at postoperative day (POD) 0 (47.8% DCD TA-NRP vs 35.2% DBD, p = 0.27), POD 1 (21.7% vs 10.6%, p = 0.16), POD2 (8.7% vs 11.7%, p = 0.68), and POD3 (13.0% vs 11.8%, p = 0.87). Other intraoperative and postoperative outcomes were not significantly different.
Conclusion
Lung transplantation outcomes were not significantly different between lung grafts recovered by DCD TA-NRP and DBD. This early data suggests TA-NRP may not adversely impact DCD lung allografts during procurement.
循环死亡(DCD)后胸腔腹腔恒温区域灌注(TA-NRP)捐献越来越多地用于心脏异体移植;然而,对其对同种异体肺移植的影响的担忧仍然存在。我们介绍了我院在DCD TA-NRP和脑死亡后肺移植(DBD)捐献方面的经验,并比较了两种技术的结果。方法纳入2022年10月至2024年12月间行DBD或DCD TA-NRP术后恢复的所有肺移植病例。DCD TA-NRP获得的肺采用肺保护策略,包括早期再插管和肺通气,如前所述。主要结局是生存,次要结局是原发性移植物功能障碍(PGD)和肺相关死亡率。结果研究期间共行DBD肺移植85例,TA-NRP肺移植23例。Kaplan-Meier曲线显示,两组患者的总生存率无显著差异(p = 0.49), DCD TA-NRP组患者的1年绝对生存率为81.6%,仅有1例肺相关死亡率;DBD组患者的1年绝对生存率为89.4%,仅有6例肺相关死亡率。术后第0天(POD) PGD 3级率无统计学差异(DCD TA-NRP 47.8% vs DBD 35.2%, p = 0.27), POD 1 (21.7% vs 10.6%, p = 0.16), POD2 (8.7% vs 11.7%, p = 0.68), POD3 (13.0% vs 11.8%, p = 0.87)。其他术中、术后结果无显著差异。结论DCD - TA-NRP术后肺移植与DBD术后肺移植预后无显著差异。这些早期数据表明,TA-NRP在移植过程中可能不会对DCD肺同种异体移植物产生不利影响。